VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1665300
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: terribly sick; This case was reported by a consumer and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown. It was unknown if the reporter considered the sickness to be related to Shingles vaccine. Additional details were provided as the case was reported by the patient. The age at vaccination was not reported. The patient got terribly sick after the second dose of Shingles vaccine.

Other Meds:

Current Illness:

ID: 1665301
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: got it; This case was reported by a consumer and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to Shingles vaccine. Additional details were provided as the case was reported by the patient. The age at vaccination was not reported. The patient got shingles after the 1st shot of Shingles vaccine.

Other Meds:

Current Illness:

ID: 1665302
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: I got them; This case was reported by a consumer and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to Shingles vaccine. Additional details were reported as the case was reported by the patient. The age at vaccination was not reported. The patient got them when he/she got the 1st shot too and the patient said did not think want to get another shot if it did not help as the patient going to get it anyway. No contact details were reported.

Other Meds:

Current Illness:

ID: 1665303
Sex: U
Age:
State:

Vax Date: 08/26/2021
Onset Date: 08/26/2021
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: arm hurt; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included COVID-19 VACCINE UNKNOWN with an associated reaction of pain in extremity (received in 6 months ago from the date of reporting) and shingles vaccine (received on an unknown date). On 26th August 2021, the patient received the 1st dose of Shingrix. On 26th August 2021, less than a day after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to Shingrix. Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had the older one 12 years ago from the date of reporting and just got the new one Thursday on the date of reporting. The arm hurt more on the Shingrix. No contact details were reported.

Other Meds:

Current Illness:

ID: 1665304
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: could not get the 2nd due to covid; This case was reported by a consumer via call center representative and described the occurrence of social problem in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received in late 2019). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown. Additional details were provided as follows: The reporter was the patient. The age at vaccination was not applicable for this report. The pharmacist reported that, the patient did not receive 2nd dose of Shingrix due to COVID, which led to social problem. The reporter asked if need to restart again. This case was linked with case US2021AMR183067, reported same reporter for different patient.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR183067:Same reporter

Other Meds:

Current Illness:

ID: 1665305
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, 7 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. The patient received the newest version of the shingles shots. 7 months after receiving Shingles vaccine, the patient got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization and laboratory confirmation were not provided.

Other Meds:

Current Illness:

ID: 1665306
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Suspected vaccination failure; Shingles twice; This case was reported by a consumer via interactive digital mediaand described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (five flare ups). On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The action taken with Shingles vaccine was unknown. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. The patient got Shingles vaccine after having five flare ups. After receiving Shingles vaccine, the patient had shingles twice. The patient stated that, as with any virus you could get it again and suggested to not get stressed out. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.

Other Meds:

Current Illness:

ID: 1665307
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: suspected vaccination failure; got it; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows The case was reported for the reporter's grandmother. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. The patient was in misery for months. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.

Other Meds:

Current Illness:

ID: 1665308
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient still got shingles. The patient had been told that happened and in a few cases, people got them more than once. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided. This case had been linked with case US2021AMR183108, reported by the same reporter.

Other Meds:

Current Illness:

ID: 1665309
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: could not get the 2nd due to covid; This case was reported by a consumer via call center representative and described the occurrence of social problem in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received in late 2019). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown. Additional details were provided as follows: The reporter was the patient's husband. The age at vaccination was not applicable for this report. The pharmacist reported that, the patient did not receive 2nd dose of Shingrix due to COVID, which led to social problem. The reporter asked if need to restart again. This case was linked with case US2021AMR183042, reported same reporter for different patient.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR183042:Same reporter

Other Meds:

Current Illness:

ID: 1665310
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows The case was reported for the reporter's father. The age at vaccination was not reported. the patient received Shingles vaccine in his 70s. The patient never had the shingles until he received Shingles vaccine. Afte receiving Shingles vaccine, the patient got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.

Other Meds:

Current Illness:

ID: 1665311
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The patient stated that the he/she had every vaccine for shingles still experienced shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1665312
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: I got the vaccines and got the shingles 2 months later; got the shingles; pain; itch; light scars; awful; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. Concurrent medical conditions included broken bones. On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and 2 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain, pruritus, scar and feels awful. On an unknown date, the outcome of the vaccination failure, shingles, pain, pruritus, scar and feels awful were unknown. It was unknown if the reporter considered the vaccination failure, shingles, pain, pruritus, scar and feels awful to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The patient got the vaccines and got the shingles 2 months later. The patient had broken bones in spine and the shingles pain was awful. The patient still had itch in 1 area and it left light scars and the patient never scratched them. This case was considered as suspected vaccination failure since the details regarding, laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness: Broken bones

ID: 1665313
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: suspected vaccination failure; got it; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient had the shingles shot and experienced shingles anyway and it was so bad. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.

Other Meds:

Current Illness:

ID: 1665314
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. The reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: This case was self-reported by the patient. The age at vaccination was not reported. The patient got shingles from Shingles shot. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1665315
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: hand shingles again after second shot in my eye and ear area\ Suspected Vaccination failure; shingles again in my eye; shingles again in ear area / still got shingles twice!; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure, ophthalmic herpes zoster and shingles were unknown. It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient had Shingles shot several years before the date of reporting when insurance did not pay for it. The patient had shingles again about 2 to 3 years ago after second Shingles shot in eye and ear area. The patient stated he/she still got shingles twice. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1665316
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: were vaccinated against shingles got shingles /suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The age at vaccination was not applicable for this report. The patients who were vaccinated against shingles got shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1665317
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: suspected vaccination failure/ both shots I have the shingles now/had the shot and I have the shingles; got it; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient had both shots of Shingles and now had the shingles. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1665318
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: two friends who got the shot, then got shingles\ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The age at vaccination was not reported. The reporter has friend who got the Shingles shot, very expensive and then got shingles. The reporter stated, he/she would support a rule where if something did not work as advertised the company would be required to pay the medical expenses incurred. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting. This case has been linked to the case US2021AMR183265 reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR183265:Same reporter

Other Meds:

Current Illness:

ID: 1665319
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: two friends who got the shot, then got shingles\ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The age at vaccination was not reported. The reporter has friend who got the Shingles shot, very expensive and then got shingles. The reporter stated, he/she would support a rule where if something did not work as advertised the company would be required to pay the medical expenses incurred. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting. This case has been linked to the case US2021AMR183256 reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR183256:Same reporter

Other Meds:

Current Illness:

ID: 1665320
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: got the shot and had a bad case of shingles/Suspected Vaccination Failure; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were reported as follows: The age at vaccination was not reported. The reporter know the patient who got the Shingles shot and had the bad case of shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1665321
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: took the shot and within a year I has the worst case of shingles/Suspected Vaccination failure; worst case of shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, less than a year after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient took the shot and within the year, the patient had the worst case of shingles. The patient's physician had ever seen and just the luck of the patient. The patient took the shot by all the means and mentioned that be aware vaccine might not work. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1665322
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: friend got shingle shot, got shingles/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were reported as follows: The case was reported by the patient's friend. The age at vaccination was not reported. The patient got the shingles shot and got the shingles again. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.

Other Meds:

Current Illness:

ID: 1665323
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: After the shot i got the shingle / Suspected vaccination failure; Got the shingle; Shingles can be debilitating; Took me to hospital because of pain; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, weakness and pain. On an unknown date, the outcome of the vaccination failure, shingles, weakness and pain were unknown. It was unknown if the reporter considered the vaccination failure, shingles, weakness and pain to be related to Shingles vaccine. Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient stated that shingles could be debilitating, after she got the shingle shot she got the shingle. Her husband and daughter took her to a hospital as she was such in pain they did not do nothing not even advice for a calamine lotion. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1665324
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: had his two shots and just got shingles /suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: The reporter was the patient's wife. The age at vaccination was not reported. The reporter stated that, her husband had 2 shots and just got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for shingles were not provided.

Other Meds:

Current Illness:

ID: 1665325
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: got shingles they both had the vaccine /suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The reporter was the patient's son or daughter. The age at vaccination was not reported. The reporter stated that, his or her mother had shingles vaccine shot and got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for shingles were not provided. This case was linked with case US2021AMR184399, reported by same reporter for different patient.

Other Meds:

Current Illness:

ID: 1665326
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: shingles shot , had shingles /suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included covid-19 vaccine for prophylaxis. On an unknown date, the patient received Shingles vaccine and covid-19 vaccine at an unknown dose and frequency. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The reporter stated that, had shingles vaccine and got shingles hurt big time. The reporter did not ever want them again. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for shingles were not provided.

Other Meds:

Current Illness:

ID: 1665327
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: got the Shingle shot and still got /suspected vaccination failure; got it; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The reporter stated that, got shingles shot and still got shingles not as bad. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for shingles were not provided.

Other Meds:

Current Illness:

ID: 1665328
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: had Shingles and also had the vaccine / suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient had Shingles and also had the vaccine when it came out. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1665329
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: I was vaccinated/ Two years later I got Shingles / suspected vaccination failure; Two years later I got Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient was vaccinated and insurance would not pay anything on it,. The patient went to drug store and paid for the shot. Two years later patient got Shingles, the doctor said it would of been a lot worse without the shot. The patient was glad that he or she had the shot. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, and laboratory test confirmation were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1665330
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: got the shingles from the damn shit shot / suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional case details were reported as follows: The reporter was patient's wife The age at vaccination was not reported. The patient got the shingles from the damn shit shot. The reporter stated that they screw off with shot. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1665331
Sex: M
Age:
State:

Vax Date:
Onset Date: 07/01/2021
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: got both shots and has been a month with shingles/ both shots last year; shingles, got so bad to; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. In July 2021, between 1 and 2 years after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional case details were reported as follows: The reporter was patient's wife. The age at vaccination was not reported. The patient got both shots last year in summer and has been a month with the shingles and got so bad to. The reporter feels bad for him. This case was considered as suspected vaccination failure, as details regarding laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.

Other Meds:

Current Illness:

ID: 1665332
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: suspected vaccination failure/got the worst case after getting the jab think VACCINE; got the worst case; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a 89-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details provided were as follows: The case was reported by patient's friend. Age at vaccination was not reported. The patient had received the jab and got the worst case of shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not be possible as no contact details available.

Other Meds:

Current Illness:

ID: 1665333
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: had them, had the shingles shot/ suspected vaccination failure; had them; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. Additional details were provided as follows: The patient self reported the case. The age at vaccination was not reported. The patient received shingle shot and got shingles this year. The follow up would not be possible as no contact details were available. This case was considered to be a suspected vaccination failure case, as the details regarding completion of primary vaccination schedule and time to onset and laboratory confirmation for shingles were unknown.

Other Meds:

Current Illness:

ID: 1665334
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: husband developed Parkinson's after his shingles shot; This case was reported by a consumer via media and described the occurrence of parkinson's disease in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced parkinson's disease (serious criteria GSK medically significant). On an unknown date, the outcome of the parkinson's disease was unknown. It was unknown if the reporter considered the parkinson's disease to be related to Shingles vaccine. Additional details were reported as follows: The case was reported by the patient's wife. The age at vaccination was not reported. The reporter said that do not take the vaccine as her husband developed Parkinson's after his shingles shot. No contact details were available.

Other Meds:

Current Illness:

ID: 1665335
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: it hurts; arm was sore; This case was reported by a consumer and described the occurrence of pain in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain, and pain in arm. On an unknown date, the outcome of the pain was unknown and the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the pain and pain in arm to be related to Shingles vaccine. Additional details were provided as the case was reported by the patient herself. The age at vaccination was not reported. The patient received the 1st dose of Shingles vaccine and the patient stated that the downside of the shot it hurts. The patient also stated that arm was sore for 3 days, but she rather had a sore arm than the shingles. The patient stated that her 2nd shot was due in October. The follow-up would not possible as no contact details were available.

Other Meds:

Current Illness:

ID: 1665336
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Getting over shingles, have had vaccination/Suspected vaccination failure; Getting over shingles; Still have some itching; Still having pain; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pruritus and back pain. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovering/resolving and the outcome of the pruritus and back pain were not recovered/not resolved. It was unknown if the reporter considered the vaccination failure, shingles, pruritus and back pain to be related to Shingles vaccine. Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had shingles vaccination and just getting over shingles. The patient still had some itching, still had some pain, mostly in back. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting. No contact details were available.

Other Meds:

Current Illness:

ID: 1665337
Sex: F
Age: 18
State: VT

Vax Date: 08/12/2021
Onset Date: 08/12/2021
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Long rash on left arm; Arm pain (at the injection site); Allergic reaction on left side; Allergic-type reaction: lip swelling; Face got really itchy; Felt like lump in her throat; Extreme fatigue; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 18-year-old female patient who received Men B NVS (Bexsero) (batch number ABXB35AA, expiry date 30th July 2022) for prophylaxis. Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis. Previously administered products included Covid vaccine with an associated reaction of injection site rash (received on an unknown date and experienced rash at the injection site after Covid 19 shot). Concurrent medical conditions included allergic reaction and epipen (has an allergic history/has an epi-pen). Concomitant products included galcanezumab (Emgality). On 12th August 2021, the patient received the 1st dose of Bexsero (intramuscular) and Bexsero Pre-Filled Syringe Device. On 12th August 2021, less than an hour after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced injection site pain, allergic reaction, lip swelling, pruritus facial, lump feeling in throat and fatigue. On 19th August 2021, the patient experienced rash. The patient was treated with benadryl (nos) (Benadryl Oral), dexamethasone (Dexamethasone Oral) and steroids nos (Steroid (Not Specified)). On 19th August 2021, the outcome of the allergic reaction, lip swelling, pruritus facial, lump feeling in throat and fatigue were recovered/resolved. On an unknown date, the outcome of the injection site pain and rash were not recovered/not resolved. The reporter considered the injection site pain, allergic reaction, lip swelling, pruritus facial, lump feeling in throat, fatigue and rash to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The case was reported by the mother of the patient. The reporter is the mother. The patient is the daughter. The patient received dose 1 of Bexsero (BEXSERO SUSP 1D/O.5ML PFS X10 10 PFS/CARTON) intramuscularly in the left deltoid. The reporter stated that, the patient would not be getting dose 2, Within 30 minutes of the injection the patient experienced an allergic-type reaction, lip swelling, face got really itchy, she felt like she had a lump in her throat, extreme fatigue almost instantly, and left arm pain (at the injection site). The patient was taken to urgent care where she was given oral Benadryl and oral dexamethasone. The reporter stated that, these medications helped, none of her symptoms got worse, most of her symptoms got better (everything except the arm pain) but they did not resolve entirely. The patient was sent home with steroid tablets, two days later she was still reacting/still itchy,so she took one of the steroid tablets and that cleared it up again. As of today on 19th August 2021) all of the mentioned symptoms have fully resolved except for the arm pain. The patient has had significant arm pain (at the injection site) for the past week. Today on 19th August 2021, the patient has a rash on her left arm, the rash showed up today. The rash was not exactly where the injection was given but slightly toward the inside of her upper arm. It was a long rash, this has not resolved. The reporter consented to follow up.

Other Meds: EMGALITY

Current Illness: Allergic reaction

ID: 1665338
Sex: F
Age: 54
State: TX

Vax Date: 06/07/2021
Onset Date: 06/07/2021
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: no energy; Difficulty falling and staying asleep; sleeping cycle changed; poor sleep; Joint pain in her hands; painful burning sensation in hand; Bleeding gums; sinus pressure, feels fluid behind her ears; problems with injected arm; increase in PMS symptoms/tender breasts; feeling unwell; experienced side effects as fatigue; Bruise at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site bruising in a 54-year-old female patient who received Herpes zoster (Shingrix) (batch number 5454X, expiry date 25th October 2022) for prophylaxis. Previously administered products included Zostavax (received on 27th February 2017). On 7th June 2021, the patient received the 1st dose of Shingrix (intramuscular). On 7th June 2021, immediately after receiving Shingrix, the patient experienced feeling unwell and fatigue. In August 2021, the patient experienced premenstrual breast pain. On an unknown date, the patient experienced injection site bruising, loss of energy, difficulty sleeping, change in sleep pattern, poor sleep, pain in joint involving hand, pain burning, gingival bleeding, sinus pressure and pain in arm. The patient was treated with decongestant nos (Decongestant). On an unknown date, the outcome of the injection site bruising and pain in arm were recovered/resolved and the outcome of the feeling unwell and pain burning were unknown and the outcome of the fatigue, loss of energy, difficulty sleeping, change in sleep pattern, poor sleep, pain in joint involving hand, premenstrual breast pain, gingival bleeding and sinus pressure were not recovered/not resolved. It was unknown if the reporter considered the injection site bruising, feeling unwell, fatigue, loss of energy, difficulty sleeping, change in sleep pattern, poor sleep, pain in joint involving hand, pain burning, premenstrual breast pain, gingival bleeding, sinus pressure and pain in arm to be related to Shingrix. Additional details were provided as follows: This case was reported by patient herself. The patient said she has excellent dental care and just saw her physician right before the Shingrix shot and everything was fine. The patient's right hand was her dominant hand. There was no history of sinus issues. The patient received Shingrix in the left deltoid. The patient states she has experienced side effects which are affecting her adversely and has been feeling unwell since shortly after receiving the Shingrix vaccine. The patient elaborated side effects, horrible fatigue or no energy (due to) not being able to sleep. She said her sleeping (cycle) totally changed [and nothing else (in her life) changed]. Difficulty falling asleep and difficulty staying asleep, poor sleep, not sleeping. Joint pain in her hands. The ring finger of each hand has a horribly painful burning sensation. The left hand was worse than the right. This flared up overnight with no explanation, no injury. Increase in PMS (Premenstrual symptoms) symptoms which were not going away: 7 days ago, she had tender breasts which was not alleviated with her usual menstrual cycle. Bleeding gums for no reason. The patient had horrible sinus pressure feels like she has fluid behind her ears and switches between ears. The patient has begun using a decongestant. The patient experienced bruise at the injection site which lasted 3 weeks. The patient had problems with arm (problems with the injected arm) which have since resolved. The reporter did not consent to follow-up.

Other Meds:

Current Illness:

ID: 1665339
Sex: F
Age: 17
State: NE

Vax Date: 11/09/2020
Onset Date: 11/09/2020
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Fibromyalgia; sensitive to pain; stomach aches; back aches; feelings of not being able to breath; low energy; not able to stand for long periods of time; hypermetabolic; atrophy of the muscles; stiff neck; pain along right arm; This case was reported by a consumer via call center representative and described the occurrence of stiff neck in a 17-year-old female patient who received Men B NVS (Bexsero) for prophylaxis. Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis. Previously administered products included Bexsero with an associated reaction of influenza like illness (1st dose received in 8th October 2020 refer case US2021AMR177042). On 9th November 2020, the patient received the 2nd dose of Bexsero (intramuscular) and Bexsero Pre-Filled Syringe Device. On 9th November 2020, less than an hour after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced stiff neck and pain in arm. On 9th July 2021, the patient experienced fibromyalgia, pain, stomach pain, back pain, difficulty breathing, energy decreased, difficulty in standing, hypermetabolism and muscle atrophy. On 16th November 2020, the outcome of the stiff neck and pain in arm were recovered/resolved. On an unknown date, the outcome of the fibromyalgia, pain, stomach pain, back pain, difficulty breathing, energy decreased, difficulty in standing, hypermetabolism and muscle atrophy were not recovered/not resolved. It was unknown if the reporter considered the stiff neck, pain in arm, fibromyalgia, pain, stomach pain, back pain, difficulty breathing, energy decreased, difficulty in standing, hypermetabolism and muscle atrophy to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional case details were reported as follows: The case was reported by patient's mother. The patient received 2nd dose of Bexsero vaccine in the right deltoid. Within the hour after receiving the Bexsero vaccine her daughter developed a stiff neck and she had pain along on her right arm, which both resolved in 7 days. The patient was diagnosed with Fibromyalgia in July 2021. Since being diagnosed with Fibromyalgia, the patient continued to be sensitive to pain, stomach aches, back aches, feelings of not being able to breath, low energy, not able to stand for long periods of time, hyper metabolic and atrophy of the muscles. The health care professional had decided not to treat her for Fibromyalgia at this time because the patient was so young. The reporter did not consent to follow-up.; Sender's Comments: US-GLAXOSMITHKLINE-US2021AMR177042:Same reporter,1st dose

Other Meds:

Current Illness:

ID: 1665340
Sex: M
Age: 60
State: FL

Vax Date: 07/22/2021
Onset Date: 07/23/2021
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: bumps extend across his whole neck; liquid comes out before the blood. The pimples have not resolved; pimples on neck/ pimples have not resolved; This case was reported by a consumer via call center representative and described the occurrence of papular rash in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 22nd July 2021, the patient received the 1st dose of Shingrix (intramuscular). On 23rd July 2021, 1 days after receiving Shingrix, the patient experienced papular rash, pustular acne and pimples. On an unknown date, the outcome of the papular rash, pustular acne and pimples were not recovered/not resolved. It was unknown if the reporter considered the papular rash, pustular acne and pimples to be related to Shingrix. Additional details were provided as follows: This case was reported by the patient himself. The patient received Shingrix in the left arm and developed about 50 large bumps on the back of his neck, from his hairline down. Patient reported that bumps are not itchy. The bumps extended across his whole neck from one ear to the other. The patient stated that he could not pop them like a pimple, but he did take a needle to one and clear liquid came out before the blood. The pimples had not resolved. Patient will be contacting his health care professional. The reporter did not consent to follow-up.

Other Meds:

Current Illness:

ID: 1665341
Sex: F
Age: 78
State: CA

Vax Date: 07/27/2021
Onset Date: 07/01/2021
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Pain at the injection site / injection site is still sensitive when touched; Redness / at injection site; Arm soreness; unable to do daily walk due to fatigue; Right shoulder was big and puffy; Fatigue; severe itching /injection site; swelling/ injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 27th July 2021, the patient received the 1st dose of Shingrix. In July 2021, 1 day after receiving Shingrix, the patient experienced injection site itching, injection site swelling, injection site joint inflammation, fatigue and walking difficulty. On 27th July 2021, the patient experienced injection site pain, injection site erythema and pain in arm. On an unknown date, the outcome of the injection site pain and pain in arm were recovering/resolving and the outcome of the injection site erythema, injection site itching, injection site swelling and fatigue were recovered/resolved and the outcome of the injection site joint inflammation and walking difficulty were unknown. It was unknown if the reporter considered the injection site pain, injection site erythema, injection site itching, injection site swelling, injection site joint inflammation, fatigue, pain in arm and walking difficulty to be related to Shingrix. Additional details were provided as follows: This case was reported by the patient herself. The patient received Shingrix and experienced pain, swelling, severe itching and redness at the injection site. The patient experienced fatigue and arm soreness. The pain at injection site and arm soreness began immediately and had greatly subsided. However, the right arm at injection site was still sensitive when touched or massaged. The swelling began on the second day after receiving dose and was at its worst by day 2 to day 4 after receiving vaccine and resolved after a week. Right shoulder was big and puffy. The itching began on the second day after receiving vaccine and lasted for 3 weeks. The redness at injection site began immediately and was resolved. The patient was unsure how and when the redness had resolved. Fatigue began the day after receiving vaccine and lasted between 5 and 7 days. The patient was unable to do her usual, daily walk due to fatigue. The patient stated that she received the dose at a special station set up at the main office, due to COVID restrictions. The reporter consented to follow up.

Other Meds:

Current Illness:

ID: 1665342
Sex: F
Age:
State: IA

Vax Date: 08/20/2021
Onset Date: 08/20/2021
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: patient had been given only the adjuvant portion; patient had been given only the adjuvant portion; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number 7C4B3, expiry date 14th November 2022) for prophylaxis. On 20th August 2021, the patient received Shingrix. On 20th August 2021, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional details were provided as follows: The patient had been given only the adjuvant portion of the Shingrix vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up.

Other Meds:

Current Illness:

ID: 1665343
Sex: F
Age: 1
State: NE

Vax Date: 08/20/2021
Onset Date: 08/20/2021
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Hiberix / reconstituted with an sterile diluent; Hiberix / reconstituted with an sterile diluent; This case was reported by a nurse via a representative and described the occurrence of wrong solution used in drug reconstitution in a 12-month-old female patient who received Hib (Hiberix) (batch number PJ7ER, expiry date 13th November 2022) for prophylaxis. On 20th August 2021, the patient received the 3rd dose of Hiberix. On 20th August 2021, unknown after receiving Hiberix, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown. Additional details were provided as the reporter stated that, Hiberix was reconstituted with an sterile diluent and administered to a female patient. Nurse states a patient was given a dose of Hiberix that was reconstituted using the saline for MMR vaccine instead of the diluent that comes with the Hiberix, which led to wrong solution used in drug reconstitution, and inappropriate dose of vaccine administered. The Nurse was not at the primary office location where vaccine administration error occurred and does not have any further details available at the time of this call. The reporter consented to follow up. This case was linked with case US2021176206, reported by same reporter for different patient.

Other Meds:

Current Illness:

ID: 1665344
Sex: F
Age:
State: CO

Vax Date: 04/13/2021
Onset Date: 07/01/2021
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Calcaneus fracture fracture that required a surgery; being on crutches with no weight bearing; This case was reported by a nurse via call center representative and described the occurrence of calcaneus fracture in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included osteoporosis. On 13th April 2021, the patient received the 1st dose of Shingrix. In July 2021, between 1 and 2 months after receiving Shingrix, the patient experienced calcaneus fracture and crutch user. On an unknown date, the outcome of the calcaneus fracture was unknown and the outcome of the crutch user was not recovered/not resolved. The reporter considered the calcaneus fracture and crutch user to be unrelated to Shingrix. Additional details were provided as follows: This case was reported by the nurse who was also the patient. The age at vaccination was not reported. The patient had received Shingrix and had a calcaneous fracture that required surgery with "placement of hardware" (the surgery was 36 days before this report). The patient was on crutches with no weight bearing and that would be a major ordeal to retrieve her vaccination card. The reporter had assessed the causality as not related to the administration of Shingrix. The reporter consented to follow up.

Other Meds:

Current Illness:

ID: 1665345
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: After series shingles around eye\Suspected vaccination failure; Shingles around eye; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included ophthalmic herpes zoster. Concomitant products included valaciclovir hydrochloride (Valtrex). On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and ophthalmic herpes zoster (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the ophthalmic herpes zoster was not recovered/not resolved. It was unknown if the reporter considered the vaccination failure and ophthalmic herpes zoster to be related to Shingrix and Shingrix. Additional details were provided as follows: This case was reported by patient himself. The age at vaccination was not reported. The patient reported that he had shingles around his eye. The patient was advised by his health care professional to get the Shingrix vaccine series. The patient received the Shingrix vaccine series as per package inserts. After getting the Shingrix vaccinations, he developed shingles again around his eye. The patient was considering getting another Shingrix vaccine. Referred to health care professional and spoke per package inserts or content. The patient did not pay any other additional information. The reporter did not consent to follow-up. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.

Other Meds: Valtrex

Current Illness:

ID: 1665346
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: experienced shingles after vaccination/ suspected vaccination failure; shingles; This case was reported by a physician via call center representative and described the occurrence of suspected vaccination failure in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not applicable for this report. The physician mentioned that, he knew that more than one patient experienced shingles after vaccination with Shingrix but did not want to share the exact number of patients. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting. The reporter consented to follow up. No more information was provided. This case has been linked to the case US2021177362 reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE-US2021177362:reporter?s case

Other Meds:

Current Illness:

ID: 1665347
Sex: M
Age: 62
State: SC

Vax Date: 08/01/2019
Onset Date: 07/26/2020
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Approx 15 outbreaks since 1st and second doses\ suspected Vaccination failure; Approximately 15 outbreaks; Rash is itchy\ rash along upper buttocks/lower back\ rash on left side; 1st dose August 2019 2nd on July 26 2020; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. On 26th July 2020, the patient received the 2nd dose of Shingrix. In August 2019, the patient received the 1st dose of Shingrix. On 26th July 2020, unknown after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and itchy rash. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the vaccination failure and drug dose administration interval too long were unknown and the outcome of the shingles and itchy rash were not recovered/not resolved. It was unknown if the reporter considered the vaccination failure, shingles and itchy rash to be related to Shingrix and Shingrix. Additional details were provided as follows: This case was reported by patient himself. The patient experienced approximately 15 outbreaks of Shingles since receiving first and second dose of Shingrix. For tolerance of 1st dose of Shingrix, refer case US2021AMR178368. The patient reported outbreak always occurs on the left side, on the upper buttocks or lower back where the waistband of the underwear lies. The patient reported rash was itchy and has the appearance on mosquito or spider bites. Less than 1 years after 1st dose of Shingrix, the patient experienced suspected vaccination failure, shingles and itchy rash. Less than 2 years after 2nd dose of Shingrix, the patient experienced vaccination failure, shingles and itchy rash. The patient reported not having an outbreak for the past 4 weeks. This case was considered as suspected vaccination failure as details time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting. The reporter consented to follow up.

Other Meds:

Current Illness:

ID: 1665348
Sex: F
Age: 65
State: CA

Vax Date: 08/18/2021
Onset Date: 08/01/2021
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Shingles two days after 1st dose; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles (had a history of shingles for several years). On 18th August 2021, the patient received the 1st dose of Shingrix .5 ml. In August 2021, 2 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to Shingrix. Additional details were provided as follows: The case was reported by the consumer for herself. The patient stated that, got her first vaccine of Shingrix on Wednesday at the time of reporting. The patient said that, two days later she had an outbreak of shingles. The reporter did not consent to follow up.

Other Meds:

Current Illness:

ID: 1665350
Sex: F
Age:
State:

Vax Date: 08/23/2021
Onset Date: 08/24/2021
Rec V Date: 09/02/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: rash where she received her injection; This case was reported by a consumer via call center representative and described the occurrence of injection site rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On 23rd August 2021, the patient received the 1st dose of Shingrix. On 24th August 2021, 1 days after receiving Shingrix, the patient experienced injection site rash. On an unknown date, the outcome of the injection site rash was unknown. It was unknown if the reporter considered the injection site rash to be related to Shingrix. Additional details were provided as follows: The case was reported by the consumer for herself. The age at vaccination was not reported. The patient stated that, she got her first Shingrix vaccine yesterday and woke up this morning on day of reporting with a rash on her arm where she received her injection. The patient declined to provide any additional information regarding this report. The reporter did not consent to follow up. The patient declined to provide any additional adverse event details.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am